Small-molecule inhibitors targeting the NLRP3 inflammasome: advances since mid-2023 and future perspectives.

Jia D, Hou Y, Wu Y, Zhang Y, Zhao Y, Gong P

DOI: 10.1039/d6md00563b
Published: 2026 Aug 10
Container: RSC medicinal chemistry
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1039/d6md00563b,
  title = {Small-molecule inhibitors targeting the NLRP3 inflammasome: advances since mid-2023 and future perspectives.},
  author = {Jia D and Hou Y and Wu Y and Zhang Y and Zhao Y and Gong P},
  year = {2026},
  journal = {RSC medicinal chemistry},
  doi = {10.1039/d6md00563b},
  url = {https://doi.org/10.1039/d6md00563b}
}

RIS

TY  - JOUR
TI  - Small-molecule inhibitors targeting the NLRP3 inflammasome: advances since mid-2023 and future perspectives.
AU  - Jia D
AU  - Hou Y
AU  - Wu Y
AU  - Zhang Y
AU  - Zhao Y
AU  - Gong P
PY  - 2026
JO  - RSC medicinal chemistry
DO  - 10.1039/d6md00563b
UR  - https://doi.org/10.1039/d6md00563b
ER  -

APA

D, J., Y, H., Y, W., Y, Z., Y, Z., & P, G. (2026). Small-molecule inhibitors targeting the NLRP3 inflammasome: advances since mid-2023 and future perspectives.. RSC medicinal chemistry. https://doi.org/10.1039/d6md00563b

Source records

pubmed · retrieved 2026-09-25T13:01:33.862Z